Gene

HLA-A

major histocompatibility complex, class I, A

Explore in graph →CI-GENE-00004452HGNC:4931 ENSG00000206503 NCBI 3105 CIViC Cancer geneApproved

Curated evidence

Clinical evidence (2)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
HLA-A Mutation1
(oncogenic)	Diffuse Large B-Cell LymphomaCURATED_BROADER	Oncogenic	E	Supports Oncogenicity	4	submitted	EID11951 The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations. PMID 29713087 · Chapuy et al., 2018 · Open in CIViC	civic
HLA-A 02:01P + HLA-A 02:02P + HLA-A 02:03P + HLA-A 02:06P + MAGEA4 ExpressionHLA-A MAGEA41
Afamitresgene Autoleucel	Synovial Sarcoma	Predictive	A	Supports Sensitivity Response	4	submitted

Cohorts

Alteration frequency by cohort (69)

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

cbioportalObserved69 cohort rows (showing 50, sorted by frequency) · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Colorectal Cancer (MSK, Cancer Discovery 2022) coadread_mskresistance_2022	Colorectal Adenocarcinoma	Ssm

Literature

Linked publications (0)

Data not yet available

No publication linked to this gene yet.